Education
About Us
Working with TipRanks
Follow Us
Bioforce Nanosciences Holdings, Inc. (BFNH)
:BFNH
BFNH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.16 - $1.88
Previous CloseN/A
Volume3.00K
Average Volume (3M)961.00
Market Cap
$14.08M
Enterprise Value$23.36M
Total Cash (Recent Filing)$13.80K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.22
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding33,521,755
10 Day Avg. Volume550
30 Day Avg. Volume961
Financial Highlights & Ratios
PEG Ratio41.03
Price to Book (P/B)-43.24
Price to Sales (P/S)0.00
P/FCF Ratio-851.76
Enterprise Value/Market Cap1.66
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-16.24
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioForce Nanosciences Holdings News
PremiumCompany Announcements
BioForce Nanosciences Delays Annual Report FilingBFNH FAQ
What was Bioforce Nanosciences Holdings, Inc.’s price range in the past 12 months?
Bioforce Nanosciences Holdings, Inc. lowest stock price was $0.16 and its highest was $1.88 in the past 12 months.
What is Bioforce Nanosciences Holdings, Inc.’s market cap?
Bioforce Nanosciences Holdings, Inc.’s market cap is $14.08M.
When is Bioforce Nanosciences Holdings, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bioforce Nanosciences Holdings, Inc.’s earnings last quarter?
Bioforce Nanosciences Holdings, Inc. released its earnings results on May 11, 2018. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.002.
Is Bioforce Nanosciences Holdings, Inc. overvalued?
According to Wall Street analysts Bioforce Nanosciences Holdings, Inc.’s price is currently Overvalued.
Does Bioforce Nanosciences Holdings, Inc. pay dividends?
Bioforce Nanosciences Holdings, Inc. does not currently pay dividends.
What is Bioforce Nanosciences Holdings, Inc.’s EPS estimate?
Bioforce Nanosciences Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bioforce Nanosciences Holdings, Inc. have?
Bioforce Nanosciences Holdings, Inc. has 33,521,755 shares outstanding.
What happened to Bioforce Nanosciences Holdings, Inc.’s price movement after its last earnings report?
Bioforce Nanosciences Holdings, Inc. reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Bioforce Nanosciences Holdings, Inc.?
Currently, no hedge funds are holding shares in BFNH
Company Description
Bioforce Nanosciences Holdings, Inc.
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. The company is based in Virginia Beach, Virginia.
Technical Analysis
Imunon
―
23andMe Holding
―
Bolt Biotherapeutics
―
Calidi Biotherapeutics
―
BullFrog AI Holdings, Inc.
―